Before you read
Subject: Johnson & Johnson has been ordered to pay $4.7bn (pounds 3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer
Excerpt: English text from the archived bilingual edition · Chinese edition
Reference text and retained source material
Johnson & Johnson has been ordered to pay $4.7bn (pounds 3.6bn) in damages to 22 women who alleged that its talc products caused them to develop ovarian cancer
A jury in the US state of Missouri initially awarded $550m in compensation and added $4.1bn in punitive damages
The verdict comes as the pharmaceutical giant battles some 9,000 legal cases involving its signature talcum powder
In the six week trial, the women and their families said they developed ovarian cancer after using baby powder and other talc products for decades
Their lawyers alleged the company knew its talcum powder was contaminated with asbestos since the 1970s but failed to warn consumers about the risks
The company denied that its products ever contained asbestos and insisted that they do not cause cancer
The pharmaceutical giant added that several studies have shown its talcum powder to be safe and insisted the verdict was a product of a "fundamentally unfair process"
The verdict is the largest payout J&J has faced over allegations its talc products cause cancer
A previous ruling in 2017 by a California jury awarded $417m (pounds 323.4m) to a woman who said she developed ovarian cancer after using the firm’s products including baby powder
However, a judge later overturned that verdict and several other legal challenges by J&J are yet to be decided
Punitive damages are often reduced by the trial judge or on appeal, and J&J has succeeded in having several jury verdicts overturned, some of them on technical grounds
Language and reading: using this material
Compare wording, tone and information order across complete passages. Positions, prices, policies, exams and statistics retain their original context and should be verified before practical use.
